Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Int J Environ Res Public Health ; 17(11)2020 06 10.
Article in English | MEDLINE | ID: covidwho-622436

ABSTRACT

The lifestyle adopted by most people in Western societies has an important impact on the propensity to metabolic disorders (e.g., diabetes, cancer, cardiovascular disease, neurodegenerative diseases). This is often accompanied by chronic low-grade inflammation, driven by the activation of various molecular pathways such as STAT3 (signal transducer and activator of transcription 3), IKK (IκB kinase), MMP9 (matrix metallopeptidase 9), MAPK (mitogen-activated protein kinases), COX2 (cyclooxigenase 2), and NF-Kß (nuclear factor kappa-light-chain-enhancer of activated B cells). Multiple intervention studies have demonstrated that lifestyle changes can lead to reduced inflammation and improved health. This can be linked to the concept of real-life risk simulation, since humans are continuously exposed to dietary factors in small doses and complex combinations (e.g., polyphenols, fibers, polyunsaturated fatty acids, etc.). Inflammation biomarkers improve in patients who consume a certain amount of fiber per day; some even losing weight. Fasting in combination with calorie restriction modulates molecular mechanisms such as m-TOR, FOXO, NRF2, AMPK, and sirtuins, ultimately leads to significantly reduced inflammatory marker levels, as well as improved metabolic markers. Moving toward healthier dietary habits at the individual level and in publicly-funded institutions, such as schools or hospitals, could help improving public health, reducing healthcare costs and improving community resilience to epidemics (such as COVID-19), which predominantly affects individuals with metabolic diseases.


Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/immunology , Diet , Inflammation/immunology , Metabolic Diseases/immunology , Pneumonia, Viral/immunology , Risk Reduction Behavior , COVID-19 , Coronavirus Infections/diet therapy , Coronavirus Infections/prevention & control , Humans , Inflammation/diet therapy , Inflammation/prevention & control , Metabolic Diseases/diet therapy , Metabolic Diseases/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/diet therapy , Pneumonia, Viral/prevention & control , Primary Prevention , SARS-CoV-2
2.
Food Chem Toxicol ; 143: 111558, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-629175

ABSTRACT

Prevention and treatment of non-communicable diseases (NCDs), including cardiovascular disease, diabetes, obesity, cancer, Alzheimer's and Parkinson's disease, arthritis, non-alcoholic fatty liver disease and various infectious diseases; lately most notably COVID-19 have been in the front line of research worldwide. Although targeting different organs, these pathologies have common biochemical impairments - redox disparity and, prominently, dysregulation of the inflammatory pathways. Research data have shown that diet components like polyphenols, poly-unsaturated fatty acids (PUFAs), fibres as well as lifestyle (fasting, physical exercise) are important factors influencing signalling pathways with a significant potential to improve metabolic homeostasis and immune cells' functions. In the present manuscript we have reviewed scientific data from recent publications regarding the beneficial cellular and molecular effects induced by dietary plant products, mainly polyphenolic compounds and PUFAs, and summarize the clinical outcomes expected from these types of interventions, in a search for effective long-term approaches to improve the immune system response.


Subject(s)
Diet, Carbohydrate-Restricted , Fatty Acids, Unsaturated/adverse effects , Inflammation/etiology , Noncommunicable Diseases , Polyphenols/adverse effects , Animals , Diet, Mediterranean , Dietary Fiber/administration & dosage , Exercise/physiology , Fatty Acids, Unsaturated/administration & dosage , Humans , Inflammation/epidemiology , Inflammation/prevention & control , Noncommunicable Diseases/epidemiology , Polyphenols/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL